Sanochemia Pharmazeutika competitorsClear all

Lava Therapeutics's top competitors include Cellis, Shanghai Henlius Biotech and Cellectar Biosciences.
Lava Therapeutics
Lava Therapeutics
Lava Therapeutics is a biotech company which develops proprietary T-cell engagers.
Cellis
Cellis
Cellis is a company that develops therapeutic and diagnostic solutions with a focus on nanotechnology, oncology, and molecular biology.
Shanghai Henlius Biotech
Shanghai Henlius Biotech
Shanghai Henlius Biotech provides clinical-stage biopharmaceutical services.
Cellectar Biosciences
Cellectar Biosciences
Cellectar Biosciences is a clinical stage biopharmaceutical company that engages in the development of targeted phospholipid drug conjugates for the treatment and imaging of cancer.
Founding Date
Founding Date
2016
Founding Date
2015
Founding Date
2009
Founding Date
1996
Type
Type
Private
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
's-Hertogenbosch, NL HQ
Locations
Zürich, CH HQ
Warszawa, PL
Locations
HQ
Locations
Madison, US HQ
Florham Park, US
Employees
Employees
4
Employees
814% increase
Employees
1273% increase
Employees
753% decrease
Alexa Website Rank
Alexa Website Rank
446649
Alexa Website Rank
N/A
Alexa Website Rank
368806
Alexa Website Rank
301103

Funding

Latest funding round
Latest funding round
$ 84.1m (2 months ago)
Latest funding round
N/A
Latest funding round
$ 156m (over 2 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 102.8m
Total funding raised
N/A
Total funding raised
$ 346m
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Cellis
HQ
Zürich, CH
Employees
8↑ 14% increase

Cellis is a company that develops therapeutic and diagnostic solutions with a focus on nanotechnology, oncology, and molecular biology.

View company
Shanghai Henlius Biotech
HQ
Employees
127↑ 3% increase

Shanghai Henlius Biotech provides clinical-stage biopharmaceutical services.

View company
Cellectar Biosciences
HQ
Madison, US
Employees
7

Cellectar Biosciences is a clinical stage biopharmaceutical company that engages in the development of targeted phospholipid drug conjugates for the treatment and imaging of cancer.

View company